Can’t Miss Interview TODAY 1pm ET with Cytonics President & CEO

by Chris Graebe | Sep 8, 2022 | Latest News

Sponsored By

Greetings Boardroom Members,

Today we have the rare pleasure of interviewing Mr. Joey Bose, the CEO and President of Cytonics.

Cytonics is a Florida-based biotech seeking not only to treat the symptoms of Osteoarthritis but to reverse the effects of the disease by restoring joint health.

Osteoarthritis (OA) is a painful joint disease where the cartilage that cushions your joints wears down over time, affecting over 600 million people worldwide.

And currently there are simply no effective therapies that can reverse the progression of the disease — because they don’t target the root cause.

Existing therapies only try to relieve the symptoms of OA.

So how is Cytonics stepping up to the plate to come up with something far better?

We will ask this question along with others including:

“Why hasn’t Big Pharma already come up with a solution to osteoarthritis?”
“What is Cytonics’ “edge”?
How will investors realize a return on their investment?”

So please tune in today at 1pm ET to find out more about how this exciting company is aiming to reverse the progression of osteoarthritis and restore damaged cartilage:

Join Us!

When: Thursday, Sept 7th, 1pm ET

Who: Cytonics President and CEO Joey Bose

Where: https://app.ragingbull.com/webinar/360

**See Disclaimers Below

62 Calef Hwy #233 Lee, New Hampshire 03861 United States

DISCLAIMER: To more fully understand RagingBull.com, LLC’s issuer-paid advertisement disclaimer and disclosure policy located at https://ragingbull.com/paid-advertisement-disclaimer/.

Issuer-paid advertisement.:This Issuer has paid RagingBull.com, LLC (“Raging Bull”) Seven-thousand five hundred in cash to run advertisements enhancing public awareness of the company. Ragingbull is currently invested in this company.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this Advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Investing in the private companies discussed in this Advertisement is highly risky. There is currently no market for trading or liquidating the securities discussed in this Advertisement and there is no guarantee that a market will develop in the future. Readers of this Advertisement bear responsibility for their own investment research and decisions and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money INVESTING OR trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Raging Bull nor any of its owners, employees OR INDEPENDENT CONTRACTORS is CURRENTLY registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.